All sites C00-96,D32-33,D42-43,D45-47,D76 235 87.5 4.5 3.2 0.7 4.1
Mouth, pharynx C00-14 5 100.0 - - - -
  Lip C00 2 100.0 - - - -
  Tongue C02 1 100.0 - - - -
  Mouth, other C03-06 1 100.0 - - - -
  Salivary glands C07-08 1 100.0 - - - -
  Pharynx C01,C09-14 1 100.0 - - - -
Digestive organs C15-26 46 79.4 7.5 6.6 1.8 4.8
  Oesophagus C15 3 78.6 - 7.1 7.1 7.1
  Stomach C16 6 93.8 3.1 3.1 - -
  Small intestine C17 2 87.5 - 12.5 - -
  Colon C18 12 96.7 - 1.6 - 1.6
  Rectum, rectosigmoid C19-20 8 100.0 - - - -
  Anus C21 0 100.0 - - - -
  Liver C22 4 52.6 15.8 10.5 10.5 10.5
  Gallbladder, bile ducts C23-24 1 57.1 14.3 14.3 - 14.3
  Pancreas C25 8 36.8 26.3 21.1 2.6 13.2
  Other digestive organs C26 1 40.0 40.0 - - 20.0
Respiratory organs C30-39 26 62.9 16.7 9.1 - 11.4
  Nose, sinuses C30-31 1 100.0 - - - -
  Larynx, epiglottis C32 2 100.0 - - - -
  Lung, trachea C33-34 24 59.2 18.3 10.0 - 12.5
  Mediastinum, pleura C38 0 100.0 - - - -
Bone C40-41 0 100.0 - - - -
Melanoma of the skin C43 7 100.0 - - - -
Skin, non-melanoma C44 12 100.0 - - - -
Mesothelioma C45 1 100.0 - - - -
Autonomic nervous system C47 - - - - - -
Soft tissues C48-49 1 85.7 - 14.3 - -
Breast C50 0 100.0 - - - -
Male genital organs C60-63 76 98.4 - 0.3 0.5 0.8
  Prostate C61 74 98.4 - 0.3 0.5 0.8
  Testis C62 2 100.0 - - - -
  Other male genital C60,C63 1 100.0 - - - -
Urinary organs C64-68 21 96.2 1.9 1.0 - 1.0
  Kidney C64 8 94.9 - 2.6 - 2.6
  Bladder and urinary tract2 C65-68 13 96.9 3.1 - - -
Eye C69 0 100.0 - - - -
Brain, central nervous system C70-72,D32-33,D42-43 6 89.7 - 6.9 - 3.4
Thyroid gland C73 1 100.0 - - - -
Other endocrine glands C74-75 0 100.0 - - - -
Illdefined or unknown C76,C80 6 42.9 28.6 14.3 3.6 10.7
Lymphoid and haematopoietic tissue C81-96,D45-47,D76 25 83.3 3.2 1.6 0.8 11.1
  Hodgkin lymphoma C81 1 100.0 - - - -
  Non-Hodgkin lymphoma C82-86,C96,D76 11 100.0 - - - -
  Malignant immunoproliferative diseases C88 0 100.0 - - - -
  Myeloma and other plasma cell tumors C90 3 56.3 6.3 12.5 6.3 18.8
  Leukaemia C91-95 7 81.8 9.1 - - 9.1
  Myelodysplastic syndromes D46 1 60.0 - - - 40.0
  Myeloproliferaitive neoplasms D45,D47 2 25.0 - - - 75.0
Not included above
  Basal cell carcinoma of the skin 51 100.0 - - - -
1 The following order of preference for confirmation of the diagnosis is used:
1. Histology (including autopsy, and bone marrow and blood smear examination in leukaemias)
2. Cytology
3. Surgery (including endoscopy), autopsy without histology, X-ray and some specified laboratory examinations
4. Clinical examination only
2 PUNLMP and ca in situ of the uroepithelium are included.